EcoBioMed Lab
RESEARCH PROJECTS
1. DESIGNING OF SAFE AND EFFECTIVE ADJUVANTS FOR NEW-GENERATION VACCINES
Vaccines are designed to educate our immune system to fight against microbes so that
we get long-term protection. New-generation vaccines based on recombinant subunits
or known chemical components are poorly immunogenic and unable to induce effective
immune response without an adjuvant. Approved adjuvants for human vaccination like
alum compounds for vaccination can boost up the immune response significantly, however,
they usually associate with limitations of toxicities. Thus, safe, and improved adjuvants
are needed to develop safe and effective vaccines. Under this perspective, we are
designing biocompatible polymeric adjuvants for new-generation vaccines.
2. MICRO- AND NANO-THERAPEUTICS FOR AUTOIMMUNE DISORDERS
Autoimmune diseases are multi-factorial complex disorders which are characterized
by chronic inflammation that leads to the progressive depletion of the localized tissues.
The prevalence of autoimmune diseases is around 1% worldwide and it is steadily increasing.
As of today, there is no permanent cure available for their treatment. However, consequential
pain and inflammation are temporarily managed by medications such as non-steroidal
anti-inflammatory drugs, corticosteroids, and anti-metabolite drugs. These drugs are
nonspecific and usually have severe side effects. So, the goal is to persistently
achieve the lowest level of inflammation with minimum side effects. We are developing
novel micro- and nano-therapeutics for safe and effective treatment of autoimmune
disorders.
FUNDING SOURCES
EcoBioMed Lab
-
Address
100 Engineering Center Box 43103 Lubbock, Texas 79409-3103 -
Phone
806.742.3451 -
Email
webmaster.coe@ttu.edu